A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

Completed · Phase 2

Conditions studied: Sinusitis

In brief

To measure the level of drug in nasal tissue and blood after taking a single 2g dose or 500mg tablets for up to 3 days.

Key facts

Study ID

NCT00232154

Run by

Pfizer

People needed

72

Starts

2005-11-01

Expected to finish

2006-06-01

Last updated by the study team

2011-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects considered by the Principal Investigator as an appropriate candidate for endoscopic sinus surgery, e.g., for the removal of the thickened and diseased mucosal tissue that blocks the ostiomeatal complex (OMC).

You may not qualify if…

• Known or suspected hypersensitivity or intolerance to any macrolide-like compound, including erythromycin, clarithromycin, azithromycin or telithromycin.

Where it is running

• Pfizer Investigational Site — Alabaster, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Hoover, Alabama, United States
• Pfizer Investigational Site — Hoover, Alabama, United States
• Pfizer Investigational Site — Fresno, California, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Augusta, Georgia, United States
• Pfizer Investigational Site — Elgin, Illinois, United States
• Pfizer Investigational Site — Elgin, Illinois, United States
• Pfizer Investigational Site — Maywood, Illinois, United States
• Pfizer Investigational Site — Carrollton, Kentucky, United States
• Pfizer Investigational Site — La Grange, Kentucky, United States
• Pfizer Investigational Site — Louisville, Kentucky, United States
• Pfizer Investigational Site — Durham, North Carolina, United States
• Pfizer Investigational Site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.